New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure

BACKGROUND: Multiple sclerosis (MS) with onset in the setting of acute SARS-CoV-2 virus infection has been reported, and reactivation of MS following non-mRNA COVID-19 vaccination has been noted, but there have only been three reports of newly diagnosed MS following exposure to mRNA COVID-19 vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Toljan, Karlo, Amin, Moein, Kunchok, Amy, Ontaneda, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656147/
https://www.ncbi.nlm.nih.gov/pubmed/34922126
http://dx.doi.org/10.1016/j.jneuroim.2021.577785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656147/
https://www.ncbi.nlm.nih.gov/pubmed/34922126
http://dx.doi.org/10.1016/j.jneuroim.2021.577785

Ejemplares similares